A phase 1b study of venetoclax and alvocidib in patients with relapsed/refractory acute myeloid leukemia

Jonas, BA; Hou, JZ; Roboz, GJ; Alvares, CL; Jeyakumar, D; Edwards, JR; Erba, HP; Kelly, RJ; Röllig, C; Fiedler, W; Brackman, D; Siddani, SR; Chyla, B; Hilger-Rolfe, J; Watts, JM

Jonas, BA (通讯作者)，Univ Calif Davis, Comprehens Canc Ctr, 4501 X Street,Suite 3016, Sacramento, CA 95817 USA.

HEMATOLOGICAL ONCOLOGY, 2023; 41 (4): 743

Abstract

Relapsed/refractory (R/R) Acute Myeloid Leukemia (AML) is a genetically complex and heterogeneous disease with a poor prognosis and limited treatment ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索